Charles River Laboratories's revenue was $4.02 billion for fiscal year 2025 (the twelve months to 27 Dec 2025), down 0.9% from fiscal 2024.
In the third quarter of fiscal 2026 (the three months to 26 Sep 2026) it was $983 million, down 2.2% from a year earlier.
Over the four quarters to 26 Sep 2026, revenue was $3.98 billion.
From Charles River Laboratories's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 4 Nov 2026.
Fiscal 2025
$4.02B
−0.9%
Q3 FY2026
$983M
−2.2% on a year
Growth over 9 years
+10.2%
a year, FY 2016–FY 2025
Revenue by fiscal year
Change on the year before, under each year. From FY 2016 to FY 2025, Charles River Laboratories's revenue went from $1.68 billion to $4.02 billion, a compound annual change of +10.2%; the highest was $4.13 billion in FY 2023.
Charles River Laboratories revenue, fiscal years
Period
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Revenue
$1.68B
$1.86B
$2.27B
$2.62B
$2.92B
$3.54B
$3.98B
$4.13B
$4.05B
$4.02B
Period end
31 Dec 2016
30 Dec 2017
29 Dec 2018
28 Dec 2019
26 Dec 2020
25 Dec 2021
31 Dec 2022
30 Dec 2023
28 Dec 2024
27 Dec 2025
Revenue by quarter
The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.
Charles River Laboratories revenue, fiscal quarters
Revenue is the total amount a company earns from its sales of goods and services in a period, before any cost is deducted, as reported on its income statement. For banks it is net revenue: net interest income plus fees and other income. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.
Charles River Laboratories's other figures
Revenue of comparable companies
Everything on CRL, in the terminal.
Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.